Larimar Therapeutics, Inc. (LRMR)
NASDAQ: LRMR · Real-Time Price · USD
3.330
+0.090 (2.78%)
At close: May 19, 2026, 4:00 PM EDT
3.390
+0.060 (1.80%)
After-hours: May 19, 2026, 7:38 PM EDT

Larimar Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
177.9185.4133.2226.7526.8370.1
Short-Term Investments
22.4751.44150.2460.0491.6-
Cash & Short-Term Investments
200.39136.85183.4586.79118.4370.1
Cash Growth
27.21%-25.40%111.38%-26.71%68.95%-24.33%
Other Current Assets
4.595.1711.853.392.312.11
Total Current Assets
204.98142.02195.390.18120.7472.2
Net Property, Plant & Equipment
2.422.693.723.763.694.46
Other Long-Term Assets
1.111.131.221.982.01
Total Assets
208.51145.84200.2395.94126.4178.67
Accounts Payable
8.585.222.421.281.691.66
Accrued Expenses
38.1258.4720.877.398.416.59
Current Portion of Leases
1.061.111.060.840.610.59
Total Current Liabilities
47.7664.824.369.5110.718.85
Long-Term Leases
2.722.964.064.714.85.41
Total Long-Term Liabilities
2.722.964.064.714.85.41
Total Liabilities
50.4867.7628.4114.2215.514.25
Common Stock
0.10.080.060.040.040.02
Additional Paid-in Capital
622.37512.78440.76270.15262.5180.65
Accumulated Other Comprehensive Income
0.010.050.150.08-0.03-
Retained Earnings
-464.44-434.83-269.16-188.55-151.61-116.25
Shareholders' Equity
158.0378.09171.8181.72110.964.41
Total Liabilities & Equity
208.51145.84200.2395.94126.4178.67
Total Debt
3.784.075.125.555.416
Net Cash (Debt)
196.61132.79178.3481.24113.0264.1
Net Cash Growth
48.06%-25.54%119.51%-28.12%76.33%-25.58%
Net Cash Per Share
2.481.822.911.854.393.73
Book Value
158.0378.09171.8181.72110.964.41
Book Value Per Share
1.991.072.801.864.313.75
Tangible Book Value
158.0378.09171.8181.72110.964.41
Tangible Book Value Per Share
1.991.072.801.864.313.75
Updated May 14, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q